ClinicalTrials.gg
Sign In

Hyperthyroidism clinical trials

The registry lists 112 studies for Hyperthyroidism across more than 10 countries. 27 are recruiting or about to start. 43 of them are mainly about Hyperthyroidism (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 3 narrower conditions too, such as Graves Ophthalmopathy: 408 studies, 119 open.

Get an email when these change. Save the Hyperthyroidism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
52
Status unknown
20
Recruiting
17
Not yet recruiting
7
Active, not recruiting
6
Terminated
4

Phase

Phase 2
13
Phase 3
8
Phase 4
6
Phase 1
5

Where

United States
25
China
11
Italy
9
Germany
7
France
5
Turkey
5

Who runs them

University Hospital, Basel, Switzerland (3) · Biohaven Therapeutics Ltd. (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Mashhad University of Medical Sciences (2) · Hospital de Clinicas de Porto Alegre (2) · Centre Hospitalier Princesse Grace (2) · Sun Yat-sen University (2) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (2)

What is being tested here

Drugs under test in Hyperthyroidism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
BHV-1300323
Methylprednisolone101
Felzartamab101
Imeroprubart101
Selenium002
Methimazole012
Propranolol002
Doxycycline002
Cholestyramine Resin012
PF-04236921001

Coming up

3phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 17 Hyperthyroidism studies recruiting now, 8 (47%) set no upper age limit and 7 (41%) stop at 75 or younger. 4 (24%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (6%) take healthy volunteers.

Recruiting studies that take each age, of 17
AgeWomenMen
104 (24%)4 (24%)
1815 (88%)15 (88%)
3016 (94%)16 (94%)
4016 (94%)16 (94%)
5016 (94%)16 (94%)
6516 (94%)16 (94%)
7513 (76%)13 (76%)
859 (53%)9 (53%)

Across all 112 studies, recruiting or not: 39% stop at 75 or younger and 25% at 65; 13% take children; 5% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperthyroidism studies take

Of 20 observational studies under Hyperthyroidism, half reached primary completion within 31 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase13 mo6–46 · 15 studies——
Observational31 mo10–48 · 20 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 112. Browse all 112 → or search them.